There is little literature regarding the barriers to the uptake of pharmacogenomics (PG) in pharmacy practice, especially with respect to Australia. To date, pharmacists have seldom been engaged in discussions of these issues. This study aimed to obtain an in-depth understanding of these barriers by interviewing pharmacists in Adelaide, South Australia. Ethics approved semistructured interviews were carried out with 21 public hospital pharmacists. Analysis of the data identified themes including: confidence to engage in PG, clinician acceptance of a pharmacist PG role, and the importance of timely and relevant PG education. Interviewees thought that pharmacists could have a greater participation in PG in the future, but they questioned whether this would be possible at the moment given, among other factors, existing time and work constraints.
INTRODUCTION
Pharmacogenomics (PG) aims to understand the genomic differences responsible for inter-individual variability in drug response and thereby improve the efficacy and/or safety of drug use by enabling personalised prescribing decisions.
1-3 Although PG is not yet common in practice outside oncology, it is expected to become increasingly more relevant to the field of medicine. [4] [5] [6] Patients have also begun to question health professionals about the potential benefits and risks of PG. 5, 7, 8 It is anticipated that pharmacists, as drug therapy experts, will have a significant role in the use of PG in the clinic. [9] [10] [11] [12] Even so, few pharmacists currently use PG, particularly outside of specialist settings. 1, 8 It is widely known that pharmacists' lack of PG knowledge and education impacts on the limited use of PG in pharmacy practice. 7, [13] [14] [15] Other barriers to pharmacist PG use may include pharmacists' attitudes, perceptions, confidence and concerns. [12] [13] [14] 16 Although the literature typically refers to these barriers, a detailed understanding is generally lacking and it is likely that the relative importance and drivers of these issues may vary between countries because of differences in health and education systems. 12, 16, 17 There has also been a lack of investigation about issues such as how pharmacists would prefer to be educated about this subject, whether pharmacists are prepared to take on PG roles and whether there are barriers to expanding the roles of pharmacists in general. 7, 12, 17, 18 The views of hospital pharmacists are particularly important as PG is likely to have more immediate applications in the hospital setting. 17 To our knowledge, practicing pharmacists have not commonly been included in discussions of these issues to any great extent. 4, 12 Hence, this study aimed to gain an in-depth understanding of the perceptions, barriers and drivers of the practice of PG among hospital pharmacists in South Australia.
Such a detailed and clinically relevant understanding of the barriers to the utilisation of PG in pharmacy practice necessitated the use of a systematic qualitative research method. [19] [20] [21] 
MATERIALS AND METHODS
Based on a review of the literature, interview questions were devised to focus on pharmacists' perceptions of the following major areas:
Current and possible future practice of PG. Barriers and drivers of pharmacists' participation in PG roles such as the interpretation of PG test results. Preferred methods for learning about PG.
Face-to-face interviews were conducted with 21 practicing pharmacists from four public hospitals across Adelaide, South Australia. Pharmacists were invited to participate in the study through brief verbal invitations made at each pharmacy department. Pharmacists were interviewed by one of the researchers (MMD) at the pharmacist's place of work during working hours. Another researcher (HMW) observed several of the interviews. Before being interviewed, participants were provided with an information sheet and gave written consent. The interviews were audio recorded. The audio recordings of the interviews were transcribed by one of the researchers (MMD) and the accuracy of the transcripts was checked by two investigators (MMD and HMW). In most cases, notes were written after the interviews to ensure that note-writing did not interfere with the process of interviewing. Interviews were conducted from May to October 2011. The study was approved by the University of South Australia's Human Research Ethics Committee.
The interviews were semistructured and allowed the interviewee or interviewer to discuss a response or idea in greater detail. The duration of each interview depended upon respondents; no time restrictions were imposed on the interviews. Data collection continued until it was considered that data saturation was reached where no new discoveries 1 were emerging from additional data. 22, 23 The framework approach, common in health-care-related qualitative research, was used to analyse interview responses. 24 Initial stages of analysis involved listening to the audio recordings, reading the transcripts and studying notes to identify an initial set of themes or categories (familiarisation). 22, 24 Subsequently, an index of all the themes by which the data could be examined was created (identifying a thematic framework). These themes were based on the predetermined study aims and issues that emerged from the data. [22] [23] [24] [25] This index or thematic framework was then applied systematically to all the data by annotating pieces of text with numerical or short text descriptor codes (indexing or coding). 22, 24, 26 Coding was performed independently by two researchers (MMD and HMW). Discussions between the two researchers resolved any interpretative differences. The coded sections of text were then rearranged according to the thematic framework (charting). These charts were used to map the range of themes and find any associations between them (mapping and interpretation). Reading and reflecting on the data was a continually repetitive process to increase familiarisation with the data and allow for a greater capacity to make sense of the data. 22, 26 Care was taken to avoid imposing researchers' attitudes and assumptions on the interviewee accounts; researchers remained aware of the potential bias originating from their different backgrounds (hospital pharmacist and biomedical scientist).
RESULTS

Demographics
Twenty-one hospital pharmacists were interviewed. Seventeen interviewees had worked for 5 years or less in their current hospital setting. The other four pharmacists had worked for 6, 8 and a half, 10 and 13 years, respectively. Clinical work described the role of most of the pharmacists (18/21). Other pharmacists worked in the dispensary (3/21), in educational roles (3/21), in clinical trials (2/21) or in medicines information (1/21). Five pharmacists had a pharmacy honours degree and four had either a masters or graduate diploma in clinical pharmacy. Two also had a bachelor of science with honours degree, one had completed a PhD.
Identification of main themes
There were a total of six main themes identified from the data as set out in Table 1 . The first theme describes pharmacists' general perceptions of a PG role. Themes 2 and 3 explain the impact of limited education and confidence on pharmacists' ability to engage in PG. The fourth theme examines the possibility of including PG with the inherent time and work constraints of hospital pharmacy practice. The importance of being proactive and working with other health professionals to develop a PG role for pharmacists is covered in the last two themes. Table 1 provides illustrative quotes of these themes.
Theme 1: general perceptions of the current role and future potential of PG in hospital pharmacy practice None of the 21 pharmacists interviewed had ever used genomic information to pre-emptively suggest drug therapy or dose. Nevertheless, just over half the pharmacists acknowledged that PG contributed to their understanding of observed drug interactions and inter-individual variability in drug response (14/21). Respondents gave examples for the following medications: abacavir, azathioprine, mercaptopurine, trastuzumab and medications associated with cytochrome P (CYP) 450 enzyme metabolism (carbamazepine, codeine, perhexiline, warfarin and 5HT 3 antagonists for nausea). A few pharmacists used terms such as 'basic' and 'simple' to describe their current use of PG information (5/21). Some had doubts about whether this current use could be considered a PG role (4/21). Seven interviewees did not think that they used PG in their pharmacy work at all. No pharmacist thought that the pharmacy profession as a whole was currently sufficiently prepared to have a PG role.
The discrepancy between what PG has promised and what it has delivered to date was generally thought to contribute to pharmacists' disillusionment with PG. Two pharmacists acknowledged that they were sceptical about the proposed benefits of PG. Another three did not believe that PG would have widespread use. There was a general consensus that not enough is currently known to be able to use PG in practice and that any PG role would only eventuate in the future (13/21) . Pharmacists also felt that overcoming the barriers to PG use would be very difficult to achieve, at least any time soon, and could not see how they would be able to start implementing PG in practice (2/21).
Theme 2: lack of timely and relevant PG education and information for pharmacists Almost all pharmacists stated that a lack of suitable education and training was a definite barrier to being able to have a PG role (18/21). They felt that their inability to apply PG to any great extent in practice was largely because of their inadequate understanding and knowledge of the subject. In particular, the pharmacists referred to the scarcity of guidelines and practical information for the use of PG (8/21).
Three interviewees stated that their pharmacy undergraduate education had presented the view that PG would only apply to future practice. Importantly, the pharmacists thought that they had hardly ever heard about the subject of PG since graduating from pharmacy school (5/21). The pharmacists also stated that they had difficulties in keeping up to date with PG because it is a constantly evolving field (4/21). A number of pharmacists suggested that the delivery of PG education and training should coincide with the emergence of PG in practice, as otherwise they would likely forget this information (9/21).
Several respondents thought that PG education should include examples or case studies indicating how to apply this science in practice (9/21). Importantly, it was stressed that this education should show pharmacists how to interpret PG test results (9/21). Another thought presented by interviewees was that PG should be taught in an integrated manner with therapeutic topics, rather than as a separate topic, to help students understand how the addition of PG information may improve therapeutic decision making (1/21).
Different pharmacists favoured different learning methods. Preferred methods included lectures, workshops, online training and reading. Pharmacists also described the following as being important: on-the-job training (3/21), education that can be completed in their own time and at their own pace (3/21) and learning that is interactive, providing the opportunity for discussion (9/21). Being able to claim continuing education points was also seen as an incentive to participate in the education (1/21). The necessity of requiring further qualifications to practice in PG was a point raised by a couple of pharmacists.
Theme 3: confidence to take on a PG role Some pharmacists stated that they did not feel confident or comfortable using PG information (6/21). Pharmacists may have viewed a PG role as a completely different activity to current pharmacy practice. Hence they suggested that pharmacists would require a substantial amount of training to take on a PG role (5/21). Other pharmacists who likened the interpretation of PG tests to present examples of therapeutic drug monitoring, such as the interpretation of renal function, appeared to be at greater ease with the prospect of incorporating PG into their existing pharmacy duties (4/21). The lack of confidence related to PG use could also have been influenced by pharmacists' lack of familiarity and experience with the subject. For instance, five pharmacists claimed that they had never heard of one of the following terms: personalised medicine, PG or PG test. In addition, pharmacists were aware of the current lack of evidence available to support the use of PG testing (13/21) and this may also have impacted upon their confidence to use this information.
Theme 4: hospital pharmacists' time and work constraints Respondents generally thought that PG information would mostly be required at the time of prescribing a medication, and if they were not involved in prescribing decisions then they would not be able to have a PG role. Many of the pharmacists acknowledged that, because of a lack of time and their occupation with other activities, they were not always able to be present during the time that a doctor prescribed a patient's drug therapy (7/21).
Pharmacists explained that whether they were involved in making therapy-related decisions also depended upon their specific activity or where they were working in the hospital (11/21). For instance, they did not think that they were involved with these decisions in the dispensary, but that specialist pharmacists (for example, working in oncology) would possibly have a greater role in this.
Theme 5: clinician acceptance of a pharmacist PG role and collaboration with clinicians Several of the respondents viewed therapy decision making, including the application of PG, as a role primarily for the medical practitioner and their inclusion in this role determined by the medical practitioner (7/21). Pharmacists thought that doctors might not have required assistance with or consulted them about PG-related decisions (5/21). Given that a doctor may already have sufficient PG knowledge, a couple of pharmacists questioned if it would be the responsibility of the pharmacy profession to take on such a PG role. Whether doctors currently asked pharmacists for PG information was also an issue raised by some pharmacists (6/21). One pharmacist pointed out that doctors might need assistance with interpreting PG information if they are less familiar with this subject or too busy to carry out these tasks. Providing PG-related advice and education for less experienced medical practitioners could be an important role for pharmacists. Furthermore, it was envisioned that interpreting PG test information would be a similar process to current examples of therapeutic drug monitoring-which pharmacists are already involved with. Some of the respondents claimed that pharmacists, as medicine experts, would at least be expected to know about PG, even if they would not be applying PG in practice themselves (3/21). However, it was also believed that doctors and other health professionals might not be aware that pharmacists may be able to provide PG-related expertise or services (1/21). The pharmacists strongly believed that any pharmacist PG role would need to be clearly justified (4/12). Interviewees highlighted the necessity and importance of working together with doctors and other health professionals to plan any future pharmacist PG role (4/21).
Theme 6: pharmacy profession leadership and proactivity required for a pharmacist PG role The implementation of PG in pharmacy practice was thought to be significantly dependent upon pharmacists' willingness to proactively develop the role (6/12). However, the pharmacists did not think that such a proactive effort was currently being undertaken.
Pharmacists' greater involvement with PG was not thought to be possible without support from leaders in the pharmacy profession (5/21) . At the same time, collaboration between leaders in different health professions including medicine and pharmacy, was considered essential for the success of a future PG role (7/21) . It was also suggested that pharmacists might not use PG unless it was made a compulsory component of pharmacy practice (1/21) .
DISCUSSION
The lack of PG use among pharmacists is commonly reported in the literature but, to our knowledge, pharmacists have seldom been consulted about their views on this subject. Our study aimed to engage pharmacists in discussions of the perceptions, barriers and drivers of PG in hospital pharmacy practice. Semistructured interviews were used, as opposed to a survey study design, to enable a more detailed and further exploration of these issues.
Themes: 1: general perceptions of the current role and future potential of PG in hospital pharmacy practice; 2: lack of timely and relevant PG education and information for pharmacists; and 3: confidence to take on a PG role The pharmacists interviewed had not been involved with PG testing and had rarely referred to genomic information to provide medication-related advice. In agreement with these findings, it is generally acknowledged that limited use of PG in pharmacy practice is particularly the case in Australia. 12, 27 Although there is scant literature regarding actual levels of PG use in pharmacy practice, some studies carried out in other countries provide some information. Most of the hospital pharmacist respondents of a recent US survey indicated that they had used their PG knowledge less than once per week and 23% had not used this information in the month before the survey. 17 Despite the expectation that PG will likely be used in hospital settings, there is little evidence to date of hospital pharmacists taking on a PG role.
Pharmacists of our study who felt disillusioned with PG or lacked confidence to use this information expressed minimal interest in incorporating PG in their practice. While there is limited literature on whether pharmacists are sceptical toward PG, there is recent evidence of debate among health professionals about the perceived benefits of PG testing. 8, 12, 14 In addition, a previous study indicated that it may be difficult to convince pharmacists that PG is a topic that they currently need to understand. 8 The notion that PG may only be important for the future, has also been reported by pharmacists of other studies. 12, 17 Findings similar to those of our study of pharmacists' lack of confidence in PG are found in a recent survey carried out in Victoria, Australia, where 202 of 291 pharmacists believed that their ability to counsel a patient about the results of a PG test was poor or very poor. 12 Participants of this survey were either hospital, community, government or industry pharmacists. Other research has shown that health professionals' self-confidence in interpreting PG test results can influence their use of these tests. 13, 14, 28 Lack of familiarity with PG mentioned by our interviewees likely contributed to their lack of confidence with this subject. Recent work has shown that pharmacists may be unsure of the definition of PG and possible PG roles. 8, 29 Respondents who saw PG testing as similar to present examples of therapeutic drug monitoring expressed a greater likelihood to have confidence in using PG. PG testing has also been likened to therapeutic drug monitoring in the literature. 11, 30, 31 Future efforts in PG education and training should aim to increase awareness of PG and highlight its importance to practice to ensure that pharmacists feel comfortable with the use of this information. 8, 16 Theme 4: hospital pharmacists' time and work constraints Interviewees suggested that it may be difficult to take on a PG role because of time constraints and occupation with other pharmacy activities. It has been acknowledged that pharmacists' already heavy workload may impact on whether they can take on PG roles. 4, 13, 18, 28 Even if pharmacists do not carry out PG testing themselves, including PG information in their practice will likely mean that they will need to spend more time counselling patients and answering questions from clinicians. 13, 28 For example, pharmacists at one US hospital can require up to 2 h to provide one clinical PG pharmacy consultation-which may include interpretation of the test result and providing recommendations for any changes to drug therapy. 30 In spite of these time requirements, PG knowledge is predicted to improve pharmacists' ability to counsel patients. 12, 13 Opinion is currently divided over whether all pharmacists or only those working in specialist areas, such as oncology, will need to devote considerable time to PG. 8, 9, 17 Deciding on what specific PG role pharmacists will have may help to determine the amount of time required to fulfil the role. Working collaboratively with other health-care professionals, including clinicians, laboratory medical scientists and genomic counsellors, could help minimise the time pharmacists will spend on a PG role. 32, 33 Themes: 5: clinician acceptance of a pharmacist PG role and collaboration with clinicians; and 6: pharmacy profession leadership and proactivity required for a pharmacist PG role Although our interviewees conceded that a pharmacist PG role could not be possible without clinician acceptance of this service, they also strongly believed that such a role would largely depend on whether pharmacists and pharmacy leaders proactively engage in its development. The interviewees questioned whether clinicians would require assistance with the interpretation of PG information. However, previous surveys have revealed that many doctors do not think they are well informed about PG testing or that they find interpretation of these test results to be difficult. 14, 30, 34, 35 Clinicians could also be too busy to perform PG roles. Moreover, clinician therapy decisions may be strengthened by pharmacist advice to ensure that medications are prescribed more appropriately. 2, 36, 37 Pharmacists could have a role in the interpretation of PG information where this is required by physicians. 2, 4, 14, 38 At the same time, the willingness of pharmacists to engage in PG is an essential requirement for the adoption of this field into mainstream clinical practice. 6, 16, 30 Limitations The limitations of our study should be considered. Prior assumptions and experience of the researchers may have influenced the study design, interpretation of the data and conclusions reached; although we critically reflected on this and attempted to minimise the effect of these possible biases. Although potential participants were made aware that no prior PG knowledge, education or practice was necessary for answering the study questions, participation in this study was voluntary and some pharmacists may have declined participation if they thought that their lack of familiarity with PG, and hence answers to the questions, would have reflected poorly on them. Nevertheless, respondents readily acknowledged their lack of understanding of the topic area. Most interviewees had practiced in their current place of work for 5 years or less. Hence, our findings may not have represented the views of pharmacists who had practiced for longer periods of time. As only a relatively small sample of pharmacists was interviewed from four hospitals in South Australia, caution should be exercised in determining whether the findings are transferable beyond this setting or state.
CONCLUSIONS
In conclusion, the pharmacists generally could not see the current importance of PG and were not clear about how and when it would be introduced into practice. They also did not feel prepared or confident to take on a PG role. Interviewees identified the need for further research investigating how to provide pharmacists with high-quality education and information that demonstrates how to integrate PG into specific therapeutic decisions. They also noted that proactive efforts and effective collaboration between different health professions will be necessary to identify the demand for and requirements of a pharmacist PG role.
